Tyche Industries [TYCHE] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Tyche Industries

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Tyche Industries wins in 11 metrics, Suven Life Sciences wins in 6 metrics, with 1 ties. Tyche Industries appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTyche IndustriesSuven Life SciencesBetter
P/E Ratio (TTM)11.90-28.01Suven Life Sciences
Price-to-Book Ratio0.9840.49Tyche Industries
Debt-to-Equity Ratio0.000.00Tie
PEG Ratio-1.09-0.34Tyche Industries
EV/EBITDA5.56-23.32Suven Life Sciences
Profit Margin (TTM)19.33%84.44%Suven Life Sciences
Operating Margin (TTM)11.77%-2,791.92%Tyche Industries
EBITDA Margin (TTM)11.77%N/AN/A
Return on Equity9.08%-146.15%Tyche Industries
Return on Assets (TTM)8.42%-118.91%Tyche Industries
Free Cash Flow (TTM)$78.21M$-1.91BTyche Industries
Dividend Yield3.84%N/AN/A
1-Year Return-21.30%46.77%Suven Life Sciences
Price-to-Sales Ratio (TTM)2.32641.26Tyche Industries
Enterprise Value$593.20M$43.40BSuven Life Sciences
EV/Revenue Ratio0.95577.38Tyche Industries
Gross Profit Margin (TTM)68.87%100.00%Suven Life Sciences
Revenue per Share (TTM)$62$0Tyche Industries
Earnings per Share (Diluted)$11.91$-8.15Tyche Industries
Beta (Stock Volatility)0.140.86Tyche Industries
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Tyche Industries vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Tyche Industries
Suven Life Sciences
Tyche Industries Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Tyche Industries-0.73%4.95%4.61%-1.35%0.35%-25.64%
Suven Life Sciences0.80%-0.17%-3.10%-15.83%58.82%63.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Tyche Industries-21.30%2.55%-47.15%160.00%585.85%427.68%
Suven Life Sciences46.77%186.97%307.88%-25.87%594.28%3,728.07%

News Based Sentiment: Tyche Industries vs Suven Life Sciences

Tyche Industries

News based Sentiment: NEGATIVE

September brought a mixed bag of results for Tyche Industries, with revenue growth offset by declining profits and a negative stock performance. The fluctuating valuation grade and bearish market trends suggest continued challenges for the company, making it a risky investment in the short term. The upcoming earnings report will be critical.

View Tyche Industries News Sentiment Analysis

Suven Life Sciences

News based Sentiment: POSITIVE

The month of October 2025 saw Suven Life Sciences benefit from both company-specific gains and a broader pharmaceutical rally, indicating a positive trend for the company. The Pfizer agreement acted as a catalyst for this positive movement, suggesting a favorable market environment.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Tyche Industries vs Suven Life Sciences

MetricTYCHESUVEN
Market Information
Market Cap i₹1.49B₹48.20B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,005185,019
90 Day Avg. Volume i2,944147,095
Last Close₹143.00₹208.70
52 Week Range₹129.10 - ₹224.50₹102.50 - ₹299.99
% from 52W High-36.30%-30.43%
All-Time High₹349.90 (Aug 17, 2020)₹338.50 (Apr 13, 2015)
% from All-Time High-59.13%-38.35%
Growth Metrics
Quarterly Revenue Growth-0.18%0.86%
Quarterly Earnings Growth-0.11%0.86%
Financial Health
Profit Margin (TTM) i0.19%0.84%
Operating Margin (TTM) i0.12%-27.92%
Return on Equity (TTM) i0.09%-1.46%
Debt to Equity (MRQ) i0.000.00
Cash & Liquidity
Book Value per Share (MRQ)₹144.76₹5.04
Cash per Share (MRQ)₹82.13₹2.75
Operating Cash Flow (TTM) i₹112.96M₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹124.07M₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield i3.84%N/A
Last 12-Month Dividend i₹5.50₹0.00

Valuation & Enterprise Metrics Analysis: Tyche Industries vs Suven Life Sciences

MetricTYCHESUVEN
Price Ratios
P/E Ratio (TTM) i11.90-28.01
Forward P/E i24.5210.55
PEG Ratio i-1.09-0.34
Price to Sales (TTM) i2.32641.26
Price to Book (MRQ) i0.9840.49
Market Capitalization
Market Capitalization i₹1.49B₹48.20B
Enterprise Value i₹593.20M₹43.40B
Enterprise Value Metrics
Enterprise to Revenue i0.95577.38
Enterprise to EBITDA i5.56-23.32
Risk & Other Metrics
Beta i0.140.86
Book Value per Share (MRQ) i₹144.76₹5.04

Financial Statements Comparison: Tyche Industries vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TYCHESUVEN
Revenue/Sales i₹127.00M₹18.67M
Cost of Goods Sold i₹39.53M₹0
Gross Profit i₹87.47M₹18.67M
Research & Development iN/A₹414.88M
Operating Income (EBIT) i₹14.95M₹-521.17M
EBITDA i₹37.14M₹-501.49M
Pre-Tax Income i₹32.60M₹-515.17M
Income Tax i₹8.28M₹0
Net Income (Profit) i₹24.32M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TYCHESUVEN
Cash & Equivalents i₹39.77M₹150.26M
Total Current Assets i₹1.21B₹754.72M
Total Current Liabilities i₹96.25M₹234.86M
Long-Term Debt i₹0N/A
Total Shareholders Equity i₹1.37B₹1.10B
Retained Earnings i₹1.19B₹-6.01B
Property, Plant & Equipment i₹68.16M₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TYCHESUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTYCHESUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i3,005185,019
Average Daily Volume (90 Day) i2,944147,095
Shares Outstanding i10.25M218.07M
Float Shares i2.94M67.61M
% Held by Insiders i0.71%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Tyche Industries vs Suven Life Sciences

MetricTYCHESUVEN
Last 12-Month Dividend i₹5.50₹0.00
Last 12-Month Dividend Yield i3.84%N/A
3-Year Avg Annual Dividend i₹3.00₹0.00
3-Year Avg Dividend Yield i1.41%N/A
3-Year Total Dividends i₹9.00₹0.00
Ex-Dividend DateSep 19, 2025N/A